Literature DB >> 26752188

Granuloma faciale: A master masquerader?

Najeeba Riyaz1.   

Abstract

Entities:  

Year:  2015        PMID: 26752188      PMCID: PMC4693368     

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
Granuloma faciale (GF) is a rare disease of unknown etiology, described by John Edwin Mackonochie Wigley (1892-1962) in 1945, as Boeck's sarcoid, and Pinkus, in 1952, suggested the term granuloma faciale.[1] It is characterized by rather asymptomatic facial papules, plaques, and nodules of varying sizes and colors.[2] Rarely, lesions may be painful or itchy. Lesions usually involve sun-exposed areas such as cheeks, nose, forehead, chin, external ear, and preauricular areas. GF lesion mimicking rhinophyma has been reported.[3] Extrafacial lesions may develop occasionally on scalp, trunk, breast, and extremities.[456] Lesions have a smooth surface with follicular accentuation giving a peau de orange appearance and occasional telangiectasia. There are rare reports of keloidal variants of GF occurring on the face and extrafacial sites such as shoulder.[67] A mucosal variant of GF, eosinophilic angiocentric fibrosis (EAF), an unusual fibrotic condition affecting the mucosa of the upper respiratory tract, has been reported recently. This is histologically identical to GF and may be associated with cutaneous lesions of GF.[8] Histologically, GF shows evidence of leukocytoclastic vasculitis with extensive fibrin deposition.[1] GF is a disease of the middle age and males are frequently affected. Although it is common in whites it has been reported rarely in Japanese and blacks. Sun exposure, polyclonal expansion of CD3+, CD4+, CD8+, and CD30+ T cells with upregulation of cytokines such as IL5[9] and gamma interferon[10] with subsequent inflammatory cell infiltration, have been thought to be etiological factors of GF. GF is supposed to be a great mimicker clinically. It may resemble several dermatoses such as Sweet syndrome, Kimura's disease, cutaneous T-cell lymphoma, pseudolymphoma, lupus erythematosus, Jessner's lymphocytic infiltration, lymphocytoma cutis, sarcoidosis, and even insect bite reaction.[2] Skin biopsy is often diagnostic even though there is no granuloma seen histologically (histologic misnomer). A grenz zone, polymorphic infiltrate composed of predominantly eosinophils, neutrophils, histiocytes, plasma cells and lymphocytes, perivascular inflammation with nuclear dust, extravasation of erythrocytes, and extensive deposition of fibrin and hemosiderin suggest that GF could be a subtype of leukocytoclastic vasculitis.[1] Of late, dermoscopy has been found to be a novel diagnostic tool for GF. Translucent whitish-grayish structureless areas, intermingled with orthogonal whitish streaks, focused and elongated telangiectasias, or a pink background with whitish areas are the reported dermoscopic findings in GF.[11] GF is usually resistant to therapy. Various treatment modes have been tried with variable effects such as topical tacrolimus,[12] topical and intralesional corticosteroids, dapsone, antimalarials, isoniazid, clofazimine,[3] and topical nitrogen mustard. A variety of surgical procedures such as surgical excision, dermabrasion, argon laser, pulsed dye laser, carbon dioxide laser, electrosurgery, and cryotherapy have been tried for the management of GF.[13]
  13 in total

1.  Granuloma faciale mimicking rhinophyma: response to clofazimine.

Authors:  E Gómez-de la Fuente; R del Rio; M Rodriguez; A Guerra; J L Rodriguez-Peralto; L Iglesias
Journal:  Acta Derm Venereol       Date:  2000 Mar-Apr       Impact factor: 4.437

2.  Granuloma faciale: distribution of the lesions and review of the literature.

Authors:  Daniel A Radin; Darius R Mehregan
Journal:  Cutis       Date:  2003-09

3.  High local interleukin 5 production in granuloma faciale (eosinophilicum): role of clonally expanded skin-specific CD4+ cells.

Authors:  A Gauger; C Ronet; C Schnopp; D Abeck; R Hein; F-M Köhn; J Ring; M Ollert; M Mempel
Journal:  Br J Dermatol       Date:  2005-08       Impact factor: 9.302

4.  Keloidal granuloma faciale with extrafacial lesions.

Authors:  Rajesh Verma; A L Das; S S Vaishampayan; Sachin Vaidya
Journal:  Indian J Dermatol Venereol Leprol       Date:  2005 Sep-Oct       Impact factor: 2.545

Review 5.  Eosinophilic angiocentric fibrosis affecting the nasal cavity. A mucosal variant of the skin lesion granuloma faciale.

Authors:  B V Burns; P F Roberts; J De Carpentier; A P Zarod
Journal:  J Laryngol Otol       Date:  2001-03       Impact factor: 1.469

6.  Granuloma faciale with disseminated extra facial lesions.

Authors:  Soheila Nasiri; Hoda Rahimi; Ali Farnaghi; Zahra Asadi-Kani
Journal:  Dermatol Online J       Date:  2010-06-15

7.  Granuloma faciale of the scalp.

Authors:  Inês Leite; Ana Moreira; Rita Guedes; Antónia Furtado; Eduarda Osório Ferreira; Armando Baptista
Journal:  Dermatol Online J       Date:  2011-04-15

8.  Immunophenotypic analysis suggests that granuloma faciale is a gamma-interferon-mediated process.

Authors:  B R Smoller; J Bortz
Journal:  J Cutan Pathol       Date:  1993-10       Impact factor: 1.587

9.  Granuloma faciale: a rare disease from a dermoscopy perspective.

Authors:  Danilo Augusto Teixeira; Bruna Estrozi; Mayra Ianhez
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

10.  Granuloma faciale with extrafacial involvement and response to tacrolimus.

Authors:  Lipy Gupta; Hira Naik; Neha Meena Kumar; Hemanta Kumar Kar
Journal:  J Cutan Aesthet Surg       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.